Novartis (NOVN)

Sector:

Medicine and Biotech Research

Index:

Swiss Market Index

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Sf 49.92
   
  • 52 Week High: Sf55.00
  • 52 Week Low: Sf39.99
  • Currency: Swiss Francs
  • Shares Issued: 2,706.19m
  • Market Cap: Sf135,093m

Novartis Overview

Novartis offers a wide range of healthcare products through its Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health Divisions.

3 Month Chart (25-05-2012)

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 4.6%
Div Cover 1.6
Op Mrgn 18.8%
ROCE 44.5%
Latest F'cast
P/E 13.6
PEG n/a
Pr/Revenue 2.4
Pr/Book 2.1
Latest F'cast
Revenue 15.7%
PBT -7.9%
EPS -10.5%
DPS 2.1%

Novartis Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 38,072.00 7,487.00 515.00¢ n/a n/a +68% 141.14¢ 0.0%
31-Dec-08 41,459.00 9,499.00 359.00¢ 15.3 n/a -30% 186.94¢ 3.4%
31-Dec-09 44,267.00 9,922.00 370.00¢ 15.9 5.3 +3% 203.00¢ 3.4%
31-Dec-10 50,624.00 11,702.00 428.00¢ 13.4 0.8 +16% 235.00¢ 4.1%
31-Dec-11 58,566.00 10,773.00 383.00¢ 14.6 n/a -10% 240.00¢ 4.3%

Novartis Forecasts

Year Ending Revenue (Sfm) Pre-tax (Sfm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 53,263.98 11,980.28 4.78Sf 10.4 0.3 +33% 2.27Sf 4.6%
31-Dec-13 54,026.70 12,756.78 5.26Sf 9.5 0.9 +10% 2.39Sf 4.9%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Novartis Top Newspaper Links

Novartis drug deal is just the tonic for GW Phar... 12-Apr-2011 Daily Mail
GW SIGNS £20M SATIVEX DEAL WITH NOVARTIS 12-Apr-2011 Express & Star
GW signs Sativex cannabis-based drug deal with N... 12-Apr-2011 Telegraph

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Novartis Market Data

Currency Swiss Francs
% Change 0.89 %
52 Week High Sf55.00
52 Week Low Sf39.99
Shares Issued 2,706.19m
Market Cap Sf135,093m

What The Brokers Say

Strong Buy 15
Buy 3
Neutral 13
Sell 2
Strong Sell 0
Total 33
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page